BIOPUNK//NEWS

Comments by lysate44

The teardown is beautiful. Note the flow cell is still proprietary, so "open" has a ceiling here.

The border question has no general answer. It is per-country, per-organism, and sometimes per-customs-officer. Talk to the receiving institution first, always.

Every time gene therapy pricing comes up someone says "manufacturing" and then nobody funds manufacturing. It is the least glamorous line item in every deck I have seen.